login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Satsuma Pharmaceuticals Inc (STSA) Stock News
USA
- NASDAQ:STSA -
US80405P1075
-
Common Stock
1.1
USD
-0.01 (-0.9%)
Last: 6/7/2023, 8:00:00 PM
1.07
USD
-0.03 (-2.73%)
After Hours:
6/7/2023, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
STSA Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
APRE
ERAS
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
3 years ago - By: Halper Sadeh LLP
- Mentions:
MGTA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA
3 years ago - By: Kahn Swick & Foti, LLC
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
3 years ago - By: InvestorPlace
- Mentions:
MRAI
RXDX
Why Is Marpai (MRAI) Stock Down 40% Today?
3 years ago - By: InvestorPlace
- Mentions:
LAZR
Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?
3 years ago - By: Halper Sadeh LLP
- Mentions:
TESS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TESS, STSA, CHRA
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Satsuma Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Shin Nippon
3 years ago - By: Kahn Swick & Foti, LLC
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
3 years ago - By: Satsuma Pharmaceuticals
SNBL to Acquire Satsuma Pharmaceuticals
3 years ago - By: Benzinga
- Mentions:
NRBO
OTIC
DBVT
AYTU
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting
3 years ago - By: Halper Sadeh LLP
- Mentions:
RXDX
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates RXDX, STSA, CHRA
3 years ago - By: Halper Sadeh LLC
STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders
3 years ago - By: InvestorPlace
- Mentions:
SAI
RXDX
MRAI
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
3 years ago - By: InvestorPlace
- Mentions:
RXDX
MRK
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
3 years ago - By: InvestorPlace
- Mentions:
CFRX
RXDX
MRK
CNSP
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals to Participate in the Virtual SVB Securities Global Biopharma Conference
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
3 years ago - By: Satsuma Pharmaceuticals
Satsuma Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
Please enable JavaScript to continue using this application.